Cholesterol ester hydrolase inhibitors
    11.
    发明公开
    Cholesterol ester hydrolase inhibitors 失效
    胆固醇酯水解酶抑制剂

    公开(公告)号:EP0428385A1

    公开(公告)日:1991-05-22

    申请号:EP90312382.6

    申请日:1990-11-13

    摘要: The compounds of the formula:
    in which R¹ is alkyl of 4 or more carbon atoms, cycloalkyl, 1-adamantyl, 2-adamantyl, 3-noradamantyl, 3-methyl-1-adamantyl, 1-fluorenyl, 9-fluorenyl, cycloalkylalkyl, phenyl, substituted phenyl, alkyl, alkoxy, halo, nitro, cyano or trifluoromethyl, phenylalkyl or substituted phenylalkyl, where the substituent on the benzene ring is alkyl, alkoxy, halo, nitro, cyano, trifluoromethyl or phenyl; R² is hydrogen, alkyl or R¹ taken with R² and the nitrogen atom to which they are attached form a heterocyclic moiety of the formula:
    wherein
    in which R⁷ is hydrogen, alkyl, hydroxy, alkanoyloxy, hydroxyalkyl, hydroxycarbonyl, alkoxycarbonyl, phenyl or substituted phenyl, in which the substituent is alkyl, alkoxy, halo, nitro, cyano, haloalkyl, perhaloalkyl or dialkylaminoalkyl; R⁸ is hydrogen or alkyl or R⁷ and R⁸ taken together are polymethylene; R⁹ is hydrogen, alkyl, phenyl or substituted phenyl, in which the substituent is alkyl, alkoxy, halo, nitro, cyano or perhaloalkyl; R¹⁰ is hydrogen, alkyl or gemdialkyl; n is one of the integers 0, 1 or 2; and R³, R⁴, R⁵ and R⁶ are, independently, hydrogen, alkyl, alkoxy, halo, nitro, cyano or perhaloalkyl, alkoxycarbonyl or hydroxycarbonyl; and when X is -NR⁹- or R⁷ is an amino alkyl group, a pharmaceutically acceptable salt thereof; useful as inhibitors of cholesterol ester hydrolase.

    摘要翻译: 下式化合物:其中R 1是4个或更多个碳原子的烷基,环烷基,1-金刚烷基,2-金刚烷基,3-金刚烷基,3-甲基-1-金刚烷基,1-芴基,9-芴基,环烷基烷基, 苯基,取代的苯基,烷基,烷氧基,卤素,硝基,氰基或三氟甲基,苯基烷基或取代的苯基烷基,其中苯环上的取代基为烷基,烷氧基,卤素,硝基,氰基,三氟甲基或苯基; R 2为氢,烷基或R 1与R 2和它们所连接的氮原子一起形成下式的杂环部分:其中R 7为氢,烷基,羟基,烷酰氧基,羟烷基,羟基羰基,烷氧基羰基,苯基或取代的苯基 其中取代基是烷基,烷氧基,卤素,硝基,氰基,卤代烷基,全卤代烷基或二烷基氨基烷基; R 7是氢或烷基或R 7和R 7一起是聚亚甲基; R 7是氢,烷​​基,苯基或取代的苯基,其中取代基是烷基,烷氧基,卤素,硝基,氰基或全卤代烷基; R 10是氢,烷基或偕二烷基; n是整数0,1或2中的一个; 和R 3,R 4,R 5和R 6独立地是氢,烷基,烷氧基,卤素,硝基,氰基或全卤代烷基,烷氧基羰基或羟基羰基; 当X是-NR 8 - 或R 7是氨基烷基时,其药学上可接受的盐; 用作胆固醇酯水解酶的抑制剂。

    Fluorooxirane carboxylates
    12.
    发明公开
    Fluorooxirane carboxylates 失效
    氟烷基羧酸酯

    公开(公告)号:EP0283168A3

    公开(公告)日:1989-06-14

    申请号:EP88301853.3

    申请日:1988-03-03

    IPC分类号: C07D303/48 A61K31/335

    CPC分类号: C07D303/48

    摘要: There are disclosed compounds of the formula
    wherein R¹ and R² are each, independently, hydrogen, hydroxy, lower alkyl, lower alkoxy, haloloweralkyl, haloloweralkyl sulfonyl, halo or nitro;
        R³ is hydrogen, lower alkyl, or aryl or 7-12 carbon atoms;
        A is -CH₂-, -O- or -S-;
        m is 1 - 8;
        n is 0 - 7, with the proviso that m + n ≦ 8;
    or a pharmacologically acceptable salt thereof, and their use as fatty acid oxidation inhibitors possessing a significantly reduced potential for impairment of normal cardiac function, and having particular utility in the treatment of glucose and fatty acid metabolism disorders, such as diabetes.

    Fluorooxirane carboxylates
    13.
    发明公开
    Fluorooxirane carboxylates 失效
    Fluoroxiran甲酸乙酯。

    公开(公告)号:EP0283168A2

    公开(公告)日:1988-09-21

    申请号:EP88301853.3

    申请日:1988-03-03

    IPC分类号: C07D303/48 A61K31/335

    CPC分类号: C07D303/48

    摘要: There are disclosed compounds of the formula
    wherein R¹ and R² are each, independently, hydrogen, hydroxy, lower alkyl, lower alkoxy, haloloweralkyl, haloloweralkyl sulfonyl, halo or nitro;
        R³ is hydrogen, lower alkyl, or aryl or 7-12 carbon atoms;
        A is -CH₂-, -O- or -S-;
        m is 1 - 8;
        n is 0 - 7, with the proviso that m + n ≦ 8;
    or a pharmacologically acceptable salt thereof, and their use as fatty acid oxidation inhibitors possessing a significantly reduced potential for impairment of normal cardiac function, and having particular utility in the treatment of glucose and fatty acid metabolism disorders, such as diabetes.

    摘要翻译: 公开了式CHEM的化合物,其中R 1和R 2各自独立地为氢,羟基,低级烷基,低级烷氧基,卤代低级烷基,卤代烷基磺酰基,卤素或硝基; R 3是氢,低级烷基或芳基或7-12个碳原子; A是-CH 2 - , - O-或-S-; m为1〜8; n为0-7,条件是m + n = 8; 或其药理学上可接受的盐,以及它们作为脂肪酸氧化抑制剂的用途,具有显着降低正常心脏功能损害的潜力,并且在治疗葡萄糖和脂肪酸代谢紊乱如糖尿病中具有特别的用途。